Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Clinical Research

Vol 8 No 2 (2023): December

Evaluation of Oxytocin Level and Its Relationship With Oxidant-Antioxidant Status in Women With Polycystic Ovarian Syndrome
Evaluasi Tingkat Oksitosin dan Hubungannya dengan Status Oksidan-Antioksidan pada Wanita dengan Sindrom Ovarium Polikistik (SOPK)



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.8.2023.7830
Published
September 6, 2023

Abstract

Polycystic Ovarian Syndrome (PCOS) is a prevalent endocrine disorder associated with infertility in a substantial number of women globally. This study aimed to investigate the potential role of oxytocin (OXT) in PCOS pathogenesis and its implications for oxidative stress. A cohort of 120 females, comprising 60 PCOS patients and 60 healthy controls, aged between 25 and 31, was examined. Serum concentrations of OXT, superoxide dismutase (SOD), and myeloperoxidase (MPO) were measured. The results revealed significantly decreased OXT levels in PCOS patients compared to controls (p<0.001). Additionally, PCOS patients exhibited elevated MPO levels and reduced SOD levels, suggesting increased oxidative stress. Furthermore, a positive correlation between OXT and SOD and a negative correlation between OXT and MPO were observed within the PCOS group. These findings highlight the potential of OXT as a diagnostic tool and predictor of ovarian response and treatment success in PCOS, emphasizing the need to target oxytocin for mitigating oxidative stress in this complex endocrine disorder.

Highlights:

  • Oxytocin Deficiency: This study identifies significantly reduced oxytocin levels in PCOS patients, shedding light on its potential role in the disorder's pathogenesis.
  • Oxidative Stress Imbalance: PCOS patients displayed an imbalance in oxidative stress markers, with elevated myeloperoxidase and reduced superoxide dismutase levels, indicating increased oxidative stress.
  • Diagnostic and Therapeutic Implications: Oxytocin emerges as a promising diagnostic tool and predictor of ovarian response and treatment success in PCOS, emphasizing its potential as a therapeutic target to mitigate oxidative stress in this complex endocrine disorder.

Keywords: PCOS,Oxytocin,Oxidative Stress,Infertility,Diagnostic Tool

References

  1. F. Z. Zangeneh, M. M. Naghizadeh, dan M. Masoumi, "Polycystic ovary syndrome and circulating inflammatory markers," International Journal of Reproductive BioMedicine, vol. 15, no. 6, hal. 375, 2017.
  2. D. A. Kirmizi, E. Baser, V. A. Turksoy, M. Kara, E. S. Yalvac, dan A. Y. Gocmen, "Are heavy metal exposure and trace element levels related to metabolic and endocrine problems in polycystic ovary syndrome?," Biological trace element research, vol. 198, no. 1, hal. 77-86, 2020.
  3. S. Shorakae, H. Teede, B. de Courten, G. Lambert, J. Boyle, dan L. J. Moran, "The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome," Seminars in reproductive medicine, vol. 33, no. 04, hal. 257-269, Juli 2015.
  4. E. Khashchenko, M. Vysokikh, E. Uvarova, L. Krechetova, V. Vtorushina, T. Ivanets, et al., "Activation of systemic inflammation and oxidative stress in adolescent girls with polycystic ovary syndrome in combination with metabolic disorders and excessive body weight," J Clin Med, vol. 9, hal. 1399, 2020.
  5. EA-SPcwg Rotterdam, "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)," Hum Reprod, vol. 19, hal. 41–7, 2004.
  6. C. R. McCartney dan J. C. Marshall, "Polycystic ovary syndrome," New England Journal of Medicine, vol. 375, no. 1, hal. 54-64, 2016.
  7. D. A. Dumesic dan J. S. Richards, "Ontogeny of the ovary in polycystic ovary syndrome," Fertility and sterility, vol. 100, no. 1, hal. 23-38, 2013.
  8. L. J. Webber, S. Stubbs, J. Stark, G. H. Trew, R. Margara, K. Hardy, dan S. Franks, "Formation and early development of follicles in the polycystic ovary," The Lancet, vol. 362, no. 9389, hal. 1017-1021, 2003.
  9. A. N. Schüring, N. Schulte, B. Sonntag, dan L. Kiesel, "Androgens and Insulin–Two Key Players in Polycystic Ovary SyndromeRecent Concepts in the Pathophysiology and Genetics of Polycystic Ovary Syndrome," Gynäkologisch-geburtshilfliche Rundschau, vol. 48, no. 1, hal. 9-15, 2008.
  10. A. M. Fulghesu, M. Ciampelli, G. Muzj, C. Belosi, L. Selvaggi, G. F. Ayala, dan A. Lanzone, "N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome," Fertility and sterility, vol. 77, no. 6, hal. 1128-1135, 2002.
  11. E. Moll, P. M. Bossuyt, J. C. Korevaar, C. B. Lambalk, dan F. van der Veen, "Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial," Bmj, vol. 332, no. 7556, hal. 1485, 2006.
  12. A. Elnashar, M. Fahmy, A. Mansour, dan K. Ibrahim, "N-acetyl cysteine vs. metformin in treatment of clomiphene citrate–resistant polycystic ovary syndrome: a prospective randomized controlled study," Fertility and sterility, vol. 88, no. 2, hal. 406-409, 2007.
  13. P. Odetti, C. Pesce, N. Traverso, S. Menini, E. P. Maineri, L. Cosso, et al., "Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes," Diabetes, vol. 52, no. 2, hal. 499-505, 2003.
  14. G. M. Pieper dan W. Siebeneich, "Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction," Journal of cardiovascular pharmacology, vol. 32, no. 1, hal. 101-105, 1998.
  15. F. J. Broekmans, M. R. Soules, dan B. C. Fauser, "Ovarian aging: mechanisms and clinical consequences," Endocrine Reviews, vol. 30, no. 5, hal. 465-493, 2009.
  16. J. M. Ho dan J. E. Blevins, "Coming full circle: contributions of central and peripheral oxytocin actions to energy balance," Endocrinology, vol. 154, no. 2, hal. 589-596, 2013.
  17. S. Y. Ying, "Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone," Endocrine Reviews, vol. 9, no. 2, hal. 267-293, 1988.
  18. M. Sharief, D. Alharoon, dan H. Mohammed, "Inhibin B as a marker for detection of ovarian activity in premature ovarian failure," J. Women’s Health Care, vol. 7, no. 434, hal. 2167-0420, 2018.
  19. H. Zhang, C. Wu, Q. Chen, X. Chen, Z. Xu, J. Wu, dan D. Cai, "Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models," PloS one, vol. 8, no. 5, hal. e61477, 2013.
  20. A. M. Pisoschi dan A. Pop, "The role of antioxidants in the chemistry of oxidative stress: A review," European journal of medicinal chemistry, vol. 97, hal. 55-74, 2015.
  21. T. Tezil dan H. Basaga, "Modulation of cell death in age-related diseases," Current pharmaceutical design, vol. 20, no. 18, hal. 3052-3067, 2014.
  22. I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, dan R. Colombo, "Protein carbonyl groups as biomarkers of oxidative stress," Clinica chimica acta, vol. 329, no. 1-2, hal. 23-38, 2003.
  23. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, dan A. Milzani, "Biomarkers of oxidative damage in human disease," Clinical chemistry, vol. 52, no. 4, hal. 601-623, 2006.
  24. R. De Bont dan N. Van Larebeke, "Endogenous DNA damage in humans: a review of quantitative data," Mutagenesis, vol. 19, no. 3, hal. 169-185, 2004.
  25. Y. Hiraku dan S. Kawanishi, "Immunohistochemical analysis of 8-nitroguanine, a nitrative DNA lesion, in relation to inflammation-associated carcinogenesis," dalam Inflammation and Cancer: Methods and Protocols: Volume 2: Molecular Analysis and Pathways, hal. 3-14, 2009.
  26. B. Halliwel, "Free radicals, antioxidants and human disease. Where are we now?," J Lab Clin Med, vol. 119, hal. 598-620, 1992.
  27. P. A. Riley, "Free radicals in biology: oxidative stress and the effects of ionizing radiation," International journal of radiation biology, vol. 65, no. 1, hal. 27-33, 1994.
  28. J. M. Gutteridge, "Biological origin of free radicals, and mechanisms of antioxidant protection," Chemico-biological interactions, vol. 91, no. 2-3, hal. 133-140, 1994.
  29. H. N. Siti, Y. Kamisah, dan J. J. Kamsiah, "The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)," Vascular pharmacology, vol. 71, hal. 40-56, 2015.
  30. J. Nijhuis, S. S. Rensen, Y. Slaats, F. M. Van Dielen, W. A. Buurman, dan J. W. M. Greve, "Neutrophil activation in morbid obesity, chronic activation of acute inflammation," Obesity, vol. 17, no. 11, hal. 2014-2018, 2009.
  31. J. Nijhuis, S. S. Rensen, Y. Slaats, F. M. Van Dielen, W. A. Buurman, dan J. W. M. Greve, "Neutrophil activation in morbid obesity, chronic activation of acute inflammation," Obesity, vol. 17, no. 11, hal. 2014-2018, 2009.
  32. B. N. Jahromi, M. H. Dabbaghmanesh, P. Bakhshaie, M. E. Parsanezhad, Z. Anvar, M. Alborzi, dkk., "Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women," Taiwanese Journal of Obstetrics and Gynecology, vol. 57, no. 4, hal. 555-559, 2018.
  33. M. Siwek, M. Sowa-Kućma, D. Dudek, K. Styczeń, B. Szewczyk, K. Kotarska, dkk., "Oxidative stress markers in affective disorders," Pharmacological Reports, vol. 65, no. 6, hal. 1558-1571, 2013.
  34. Z. Zou, H. Chang, H. Li, dan S. Wang, "Induction of reactive oxygen species: an emerging approach for cancer therapy," Apoptosis, vol. 22, hal. 1321-1335, 2017.
  35. F. González, J. Minium, N. S. Rote, dan J. P. Kirwan, "Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome," The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 9, hal. 5336-5342, 2005.
  36. M. Yilmaz, N. Bukan, G. Ayvaz, A. Karakoç, F. Toruner, N. Çakir, dan M. Arslan, "The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome," Human Reproduction, vol. 20, no. 12, hal. 3333-3340, 2005.
  37. A. Agarwal, A. Aponte-Mellado, B. J. Premkumar, A. Shaman, dan S. Gupta, "The effects of oxidative stress on female reproduction: a review," Reproductive biology and endocrinology, vol. 10, hal. 1-31, 2012.
  38. M. E. F. Vázquez-Vela, N. Torres, dan A. R. Tovar, "White adipose tissue as endocrine organ and its role in obesity," Archives of medical research, vol. 39, no. 8, hal. 715-728, 2008.
  39. S. B. Lecke, D. Morsch, dan P. M. Spritzer, "Circulating levels and subcutaneous adipose tissue gene expression of pigment epithelium-derived factor in polycystic ovary syndrome and normal women: a case control study," Reproductive Biology and Endocrinology, vol. 11, hal. 1-7, 2013.
  40. R. A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H. F. Escobar-Morreale, W. Futterweit, dkk., "Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society," The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 5, hal. 2038-2049, 2010.
  41. A. J. Duleba dan A. Dokras, "Is PCOS an inflammatory process?," Fertility and sterility, vol. 97, no. 1, hal. 7-12, 2012.
  42. E. Carmina, M. C. Chu, R. A. Longo, G. B. Rini, dan R. A. Lobo, "Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters," The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 5, hal. 2545-2549, 2005.
  43. A. L. Ribeiro, A. Scapinelli, S. Tamanaha, R. M. de Oliveira, I. Kowastch, W. M. Junior, dkk., "Myeloperoxidases and polycystic ovary syndrome," Gynecological Endocrinology, vol. 28, no. 1, hal. 3-6, 2012.
  44. Z. Kurdoglu, H. Ozkol, dan M. Kurdoglu, "Serum myeloperoxidase and adenosine deaminase activities in polycystic ovary syndrome," Gynecological Endocrinology, vol. 28, no. 2, hal. 115-118, 2012.
  45. R. Koca, F. Armutcu, H. C. Altinyazar, dan A. Gürel, "Oxidant‐antioxidant enzymes and lipid peroxidation in generalized vitiligo," Clinical and experimental dermatology, vol. 29, no. 4, hal. 406-409, 2004.
  46. O. Arican, E. B. Kurutas, dan S. Sasmaz, "Oxidative Stress in Patients With Acne Vulgaris," Mediators of Inflammation, vol. 2005, hal. 380-384, 2005.
  47. P. Y. Basak, F. Gultekin, dan I. Kilinc, "The role of the antioxidative defense system in papulopustular acne," The Journal of dermatology, vol. 28, no. 3, hal. 123-127, 2001.
  48. E. B. Kurutas, O. Arican, dan S. Sasmaz, "Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris," Acta Dermatovenerol Alp Panonica Adriat, vol. 14, no. 2, hal. 39-42, 2005.
  49. L. Roushangar, J. Soleymanirad, P. NIKPOU, dan M. Sayahmeli, "Effect of oxytocin injection on folliculogenesis, ovulation and endometrial growth in mice."
  50. M. Sayyah-Melli, E. Ouladsahebmadarek, S. Tagavi, P. M. Garabaghi, M. Alizadeh, M. Ghojazadeh, dan M. Kazemi-Shishvan, "Effect of oxytocin (OT) and OT plus human chorionic gonadotropin (hCG), in cycles induced by letrozole or clomiphene citrate (CC)," African Journal of Pharmacy and Pharmacology, vol. 6, no. 28, hal. 2112-2118, 2012.
  51. H. E. Ross, C. D. Cole, Y. Smith, I. D. Neumann, R. Landgraf, A. Z. Murphy, dan L. J. Young, "Characterization of the oxytocin system regulating affiliative behavior in female prairie voles," Neuroscience, vol. 162, no. 4, hal. 892-903, 2009.
  52. D.T.B.H. Baird, J. EscobarMorreale, L.H. Evers, B.C.J.M. Fauser, S. Franks, A. Glasier, et al., "Health and fertility in world health organization group2 anovulatory women," Human Reproduction Update, vol. 18, no. 5, hal. 586-599, 2012.
  53. A. M. Pisoschi dan A. Pop, "The role of antioxidants in the chemistry of oxidative stress: A review," European journal of medicinal chemistry, vol. 97, hal. 55-74, 2015.
  54. T. Tezil dan H. Basaga, "Modulation of cell death in age-related diseases," Current pharmaceutical design, vol. 20, no. 18, hal. 3052-3067, 2014.
  55. N. Anatoliotakis, S. Deftereos, G. Bouras, G. Giannopoulos, D. Tsounis, C. Angelidis, dkk., "Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease," Current topics in medicinal chemistry, vol. 13, no. 2, hal. 115-138, 2013.
  56. S. J. Klebanoff, "Myeloperoxidase: friend and foe," Journal of leukocyte biology, vol. 77, no. 5, hal. 598-625, 2005.
  57. C. Zhang, J. Yang, dan L. K. Jennings, "Leukocyte-derived myeloperoxidase amplifies high-glucose—induced endothelial dysfunction through interaction with high-glucose—stimulated, vascular non—leukocyte-derived reactive oxygen species," Diabetes, vol. 53, no. 11, hal. 2950-2959, 2004.
  58. D. Zhang, WY. Luo, H. Liao, CF. Wang, dan Y. Sun, "The effects of oxidative stress to PCOS," Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 39, no. 3, hal. 421–3, 2008.
  59. S. Rajendran, S. R., W. P. A. Chan, E. Liberts, T. Heresztyn, M. Saha, dkk., "Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects," Atherosclerosis, vol. 204, no. 2, hal. 509-514, 2009.
  60. F. González, N. S. Rote, J. Minium, dan J. P. Kirwan, "Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome," The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 1, hal. 336-340, 2006.
  61. I. B. Lamster dan M. J. Novak, "Host mediators in gingival crevicular fluid: implications for the pathogenesis of periodontal disease," Critical Reviews in Oral Biology & Medicine, vol. 3, no. 1, hal. 31-60, 1992.
  62. G. R. Brock, C. J. Butterworth, J. B. Matthews, dan I. L. C. Chapple, "Local and systemic total antioxidant capacity in periodontitis and health," Journal of clinical periodontology, vol. 31, no. 7, hal. 515-521, 2004.
  63. B. Halliwell dan J.M. Gutteridge, "Role of free radicals and catalytic metal ions in human disease: An overview," Methods Enzymol, vol. 186, hal. 1–85, 1990.

Downloads

Download data is not yet available.